IMDX

Insight Molecular Diagnostics Inc. Common Stock
IMDX

Overview Fund Activity

47 hedge funds and large institutions have $21.1M invested in Insight Molecular Diagnostics Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 11 closing their positions.

Holders
47
Holders Change
-5
Holders Change %
-9.62%
% of All Funds
0.74%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
13
Reduced
7
Closed
11
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
+$2K

Top Buyers

1
BC
1
Broadwood Capital
New York
$11.5M
2
AIC
2
AWM Investment Company
New York
$3.26M
3
Morgan Stanley
3
Morgan Stanley
New York
$642K
4
Citadel Advisors
4
Citadel Advisors
Florida
$57.9K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$283K

Top Sellers

1
PVI
1
Pura Vida Investments
New York
$3.13M
2
PM
2
Penbrook Management
New York
$0
3
BCM
3
Bridgeway Capital Management
Texas
$0
4
BlackRock
4
BlackRock
New York
$279K
5
Millennium Management
5
Millennium Management
New York
$77.7K
Name Holding Trade Value Shares
Change 		Shares
Change %
Susquehanna International Group
51
Susquehanna International Group
Pennsylvania
– -$12.3K -1,739 Closed
Deutsche Bank
52
Deutsche Bank
Germany
– -$12K -1,695 Closed
Jane Street
53
Jane Street
New York
– -$8.79K -1,240 Closed
WW
54
Westshore Wealth
California
– -$7.09K -1,000 Closed
LP
55
LMR Partners
United Kingdom
– -$3.54K -500 Closed
FCH
56
Freestone Capital Holdings
Washington
– -$3.54K -500 Closed
Citigroup
57
Citigroup
New York
– -$49 -7 Closed
Group One Trading
58
Group One Trading
Illinois
– -$9 -1 Closed
1 2
3